<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>278019</rcn>
  <id>101221376</id>
  <acronym>Immuno-SBC</acronym>
  <teaser>"Approximately 1 in 5 newly diagnosed cancers is a second or subsequent cancer related to treatment for a first cancer. Second breast cancers (SBCs) are the most commonly diagnosed. Those who develop SBCs have reduced treatment options and worse outcomes than comparable...</teaser>
  <objective>"Approximately 1 in 5 newly diagnosed cancers is a second or subsequent cancer related to treatment for a first cancer. Second breast cancers (SBCs) are the most commonly diagnosed. Those who develop SBCs have reduced treatment options and worse outcomes than comparable individuals with first primary breast cancers. There are over 12 million female cancer survivors in the EU, of whom at least 15% will develop an SBC. A better understanding of the etiology and risk factors for SBC is therefore essential. There is an intriguing and poorly understood negative association between systemic autoimmune diseases and breast cancer, repeatedly documented in distinct populations. My preliminary data further suggests that systemic autoimmune disease interacts with chemotherapy receipt to modify the risk of SBCs. However, no research groups have interrogated the interaction among autoimmunity, cancer treatment, and SBC risk. I propose to address this gap by bringing together population-based studies, multi-omic tools, and innovative statistical modelling. I have proposed three complementary Scientific Aims to understand the epidemiological and biological relevance of autoimmune disease in SBC. In Aim 1, I will use a novel approach to link large cohorts of cancer survivors with medical data to capture the course of autoimmune disease after cancer and its relationship with SBC risk. In Aim 2, I will use germline genotyping data to define ""autoimmune states"" reflecting the true range of sub-clinical autoimmune phenotypes. In Aim 3, I will test the association between autoimmune state and SBC risk, and the interaction with chemotherapy. This project thus introduces a novel paradigm for understanding of the etiology of treatment-associated cancers. Given the fundamental importance of immune state in cancer outcomes, and the number of people at risk of SBC, this project will have a profound impact on cancer survivorship research."</objective>
  <title>Disentangling the relationship between autoimmunity, cancer treatment, and risk of subsequent breast cancer</title>
  <totalCost>1499732</totalCost>
  <ecMaxContribution>1499732</ecMaxContribution>
  <startDate>2026-01-01</startDate>
  <endDate>2030-12-31</endDate>
  <ecSignatureDate>2025-10-13</ecSignatureDate>
  <duration>60</duration>
  <status>SIGNED</status>
  <keywords>breast cancer,  autoimmunity,  chemotherapy,  radiotherapy,  genetics,  statistical modelling,  late effects,  cancer survivorship</keywords>
  <identifiers>
    <grantDoi>10.3030/101221376</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-10-20 17:38:03</sourceUpdateDate>
  <contentCreationDate>2025-10-27 12:14:47</contentCreationDate>
  <contentUpdateDate>2025-10-27 12:14:45</contentUpdateDate>
  <lastUpdateDate>2025-11-03 09:43:29</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>57053</rcn>
        <title>ERC-2025-STG</title>
        <identifier>ERC-2025-STG</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>57053</rcn>
        <title>ERC-2025-STG</title>
        <identifier>ERC-2025-STG</identifier>
      </call>
      <organization netEcContribution="1336500" totalCost="1336500" source="corda" order="1" ecContribution="1336500" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1908705</rcn>
        <id>999984738</id>
        <vatNumber>NL002562169B01</vatNumber>
        <legalName>STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS</legalName>
        <shortName>NKI AVL</shortName>
        <address>
          <street>PLESMANLAAN 121</street>
          <city>AMSTERDAM</city>
          <postalCode>1066 CX</postalCode>
          <country>NL</country>
          <postBox>N/A</postBox>
          <url>http://www.nki.nl</url>
          <geolocation>52.351147,4.8251087</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <rcn>1471664</rcn>
              <nutsCode>NL32B</nutsCode>
            </region>
            <region type="relatedRegion">
              <name>Netherlands</name>
              <rcn>391547432</rcn>
              <nutsCode>NL</nutsCode>
              <euCode>NL</euCode>
              <isoCode>NL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="163232" totalCost="163232" source="corda" order="2" ecContribution="163232" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>2261199</rcn>
        <id>935256153</id>
        <vatNumber>NL851260846B01</vatNumber>
        <legalName>PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV</legalName>
        <shortName>PrinsesMaximaCentrumvoorKinderoncologie</shortName>
        <address>
          <street>HEIDELBERGLAAN 25</street>
          <city>Utrecht</city>
          <postalCode>3584CS</postalCode>
          <country>NL</country>
          <postBox>113</postBox>
          <url>http://www.prinsesmaximacentrum.nl</url>
          <geolocation>52.1038467,5.19093085070224</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/OTH</code>
              <title>Other</title>
              <displayCode>/Other</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <rcn>1471669</rcn>
              <nutsCode>NL350</nutsCode>
            </region>
            <region type="relatedRegion">
              <name>Netherlands</name>
              <rcn>391547432</rcn>
              <nutsCode>NL</nutsCode>
              <euCode>NL</euCode>
              <isoCode>NL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705727</rcn>
        <id>HORIZON.1.1</id>
        <code>HORIZON.1.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.1</pga>
        <title>European Research Council (ERC)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>709265</rcn>
        <id>HORIZON_ERC-2025-STG</id>
        <code>ERC-2025-STG</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>ERC STARTING GRANTS</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode>/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-ERC</code>
        <title>HORIZON ERC Grants</title>
        <description>HORIZON ERC Grants</description>
        <displayCode>/HORIZON ERC Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>